Successful Use of Intravenous Immunoglobulins in an Obinutuzumab-related Acute Thrombocytopenia

Hemasphere. 2022 Jul 15;6(8):e751. doi: 10.1097/HS9.0000000000000751. eCollection 2022 Aug.
No abstract available